Interview with Pharma Boardroom

Our CEO Dr. Ryu Ogawa and CSO Dr. Satoshi Tamaki were interviewed by Pharma Boardroom about MOLCURE’s impact in the drug discovery process. Pharma boardroomに弊社の小川(CEO)と玉木(CSO)のインタビューが掲載されました。 Link to article can be found here.
Read more

Interview with Voices of Leaders

Molcure CEO Ryu Ogawa and CSO Satoshi Tamaki talk to @VoicesofLeaders about how AI will transform the field of biotechnology. Voices of Leadersに弊社の小川(CEO)と玉木(CSO)のインタビュー「AIはバイオテクノロジー業界をどう変革するか」が掲載されました。 Link to article: https://vol.media/vol_bytes/85
Read more

MOLCURE included in team building case studies

The Ministry of Economy, Trade & Industry includes MOLCURE in its case studies for team building, highlighting its importance for company growth. 経済産業省が発行した「大学発ベンチャーチームビルディング事例集」にMOLCUREの活躍が紹介されました。 Link to article: https://www.meti.go.jp/press/2020/05/20200515003/20200515003-3.pdf
Read more

We are moving!

Due to business expansion, MOLCURE is moving its head office from Shinagawa to Kawasaki and will be based in the AIRBIC complex. 本社オフィス移転のお知らせ。事業拡大に伴い、本社オフィスを品川産業支援交流施設から、かわさき新産業創造センター・AIRBICに移転しました。
Read more